T cells isolated from cholesterol-rich liver and tumour tissues were boosted to a greater extent than those from the blood of the same donors [42]; suggesting a similar enhancement may be seen following ACAT inhibition of SARS-CoV-2-specific T cells infiltrating the infected lung. The gene discussed is ACAT1; the disease is neoplasm.